Test Price
5,000 AED✅ Home Collection Available
Thyroid Cancer Prognostication NGS Panel in UAE – 5,000 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital extraction only – sample collection conducted strictly within accredited facilities; mobile home phlebotomy disabled for safety.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by a DHA‑licensed specialist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) panel analyzes DNA and RNA from tissue or fine needle aspirate samples to detect somatic mutations, gene fusions, and expression patterns driving thyroid cancer, enabling precise prognostication and targeted therapy selection. Results are delivered within 4 weeks and interpreted by expert specialists in Dubai.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single‑Gene BRAF Test) |
|---|---|---|
| Precision | High analytical sensitivity & specificity for multi‑gene aberrations | Limited to one hotspot mutation; may miss aggressive drivers |
| Methodology | Next‑Generation Sequencing (NGS) – comprehensive genomic profiling | Sanger sequencing or allele‑specific PCR – narrow scope |
| Turnaround Time | 4 weeks (standard) | 2–3 weeks (similar, but incomplete information) |
Physician Insight & Safety Protocols
“As a Specialist Diagnostic Radiology with extensive experience in thyroid imaging, I understand the critical role molecular profiling plays in guiding treatment. This NGS panel provides a comprehensive genomic landscape that, when correlated with ultrasound and histopathology, enables precise prognostication and personalized therapy.”
— Mr. Prabhakar Reddy Kalathoor, DHA License: 61713011
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Altering thyroid hormone therapy or anti‑coagulants can cause serious harm.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with uncorrectable coagulopathy (INR >1.5), active infection at the biopsy site, inability to discontinue anticoagulants/antiplatelets per guidelines, or inability to provide informed consent. Alternative non‑invasive sampling may be considered after specialist review. All procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If you experience sudden severe neck swelling, difficulty breathing or swallowing, high fever (>38.5°C), or uncontrolled bleeding following a biopsy, seek immediate emergency medical care.
Patient FAQ & Clinical Guidance
1. What does the Thyroid Cancer Prognostication NGS Panel test for?
Our panel sequences multiple thyroid cancer genes, detecting BRAF, RAS, RET, and TERT mutations, to predict tumor recurrence and drug sensitivity. Beyond individual mutations, the assay identifies gene fusions (e.g., RET/PTC, PAX8/PPARγ) and provides a comprehensive prognostic score that helps oncologists decide on active surveillance versus aggressive intervention.
2. How is the sample collected?
Sample collection (fine needle aspiration or tissue biopsy) is performed exclusively within an accredited hospital facility by a qualified clinician. Home phlebotomy is not available for this invasive procedure. The sample is then transported under ISO‑certified cold‑chain conditions to our laboratory.
3. Will insurance cover this?
We verify direct billing with major UAE insurers like Daman, AXA, and Neuron via WhatsApp +971 54 548 8731 before testing. Our billing team contacts your insurer with your policy details to confirm coverage limits and any co‑payment. Most comprehensive oncology plans cover prognostic NGS panels under applicable regulations.
UAE Regulatory & Data Privacy Adherence
We strictly comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and operates under DHA License No. 1143. All patient data is encrypted and handled with strict confidentiality.
Clinical & Logistical Metadata
| Test Name | Thyroid Cancer Prognostication NGS Panel |
| Price (AED) | 5,000 AED |
| Turnaround Time | 4 weeks (28 days) |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Next-Generation Sequencing (NGS) – Comprehensive genomic profiling of DNA and RNA. |
| ICD-10-CM Code | C73 |
| LOINC Code | 98542-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians